SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019393
Filing Date
2024-07-08
Accepted
2024-07-08 19:59:14
Documents
2
Period of Report
2024-06-28

Document Format Files

Seq Description Document Type Size
1 form3-07082024_110711.html 3  
1 form3-07082024_110711.xml 3 1752
2 ex24-07082024_110713.htm EX-24 6291
  Complete submission text file 0001415889-24-019393.txt   9503
Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
PFREUNDSCHUH PETER P. (Reporting) CIK: 0001585839 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38650 | Film No.: 241106125

Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)